Assessing the long-term safety and efficacy of COVID-19 vaccines.
作者信息
Majeed Azeem, Papaluca Marisa, Molokhia Mariam
机构信息
Department of Primary Care & Public Health, School of Public Health, Imperial College London, London W6 8RP, UK.
Pharmaceutical Regulatory Science and Innovation, Department of Public Health Sciences, King's College London, London SE1 1UL, UK.
出版信息
J R Soc Med. 2021 Jul;114(7):337-340. doi: 10.1177/01410768211013437. Epub 2021 May 4.
Abstract
摘要
相似文献
1
Assessing the long-term safety and efficacy of COVID-19 vaccines.评估新冠疫苗的长期安全性和有效性。
J R Soc Med. 2021 Jul;114(7):337-340. doi: 10.1177/01410768211013437. Epub 2021 May 4.
2
Accelerating vaccine trials.加速疫苗试验。
Bull World Health Organ. 2021 Jul 1;99(7):482-483. doi: 10.2471/BLT.21.020721.
3
COVID-19 vaccines, hesitancy and mental health.2019冠状病毒病疫苗、犹豫态度与心理健康
Evid Based Ment Health. 2021 May;24(2):47-48. doi: 10.1136/ebmental-2021-300266. Epub 2021 Apr 13.
4
Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada.加拿大原住民中的医学实验与新冠疫苗犹豫情绪的根源
CMAJ. 2021 Mar 15;193(11):E381-E383. doi: 10.1503/cmaj.210112. Epub 2021 Feb 24.
5
Intention to Vaccinate Children Against COVID-19 Among Vaccinated and Unvaccinated US Parents.美国已接种和未接种疫苗的父母对子女接种 COVID-19 疫苗的意愿。
JAMA Pediatr. 2022 Feb 1;176(2):201-203. doi: 10.1001/jamapediatrics.2021.5153.
6
Addressing the elephant in the room: COVID-19 vaccine hesitancy in Black and Asian communities.直面房间里的大象：黑人和亚裔社区对新冠疫苗的犹豫态度。
Br J Gen Pract. 2021 Mar 26;71(705):170. doi: 10.3399/bjgp21X715433. Print 2021 Apr.
7
Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence.考虑在新冠疫苗沟通中融入情感：解决疫苗犹豫问题，增强疫苗信心。
Health Commun. 2020 Dec;35(14):1718-1722. doi: 10.1080/10410236.2020.1838096. Epub 2020 Oct 30.
8
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.COVID-19 疫苗和疫苗犹豫：过敏症/免疫学家在促进疫苗接种方面的作用。
Allergy Asthma Proc. 2021 Sep 9;42(5):386-394. doi: 10.2500/aap.2021.42.210063. Epub 2021 Aug 9.
9
For the patient: COVID-19 vaccines and the public challenges and solutions.针对患者：新冠病毒疫苗以及公共挑战与解决方案。
Allergy Asthma Proc. 2021 Jan 1;42(1):100. doi: 10.2500/aap.2021.42.200118.
10
People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats.在健康威胁加剧时，人们对预防措施的看法、采取预防措施的意愿以及接种疫苗的意愿。
PLoS One. 2022 Feb 2;17(2):e0263351. doi: 10.1371/journal.pone.0263351. eCollection 2022.
引用本文的文献
1
Impact of COVID-19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase.2019冠状病毒病对血液系统癌症患者的影响：大流行后期阶段的见解
Cancer Med. 2025 Aug;14(15):e71112. doi: 10.1002/cam4.71112.
2
Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.在孟加拉国成年人中，与牛津-阿斯利康疫苗同源和异源剂量相关的副作用：一项观察性研究。
Sci Rep. 2024 Oct 11;14(1):23794. doi: 10.1038/s41598-024-75833-z.
3
Is There a Correlation Between Periodontal Disease Symptoms and the COVID-19 Vaccination?牙周疾病症状与新冠疫苗接种之间存在关联吗？
Cureus. 2024 Apr 24;16(4):e58892. doi: 10.7759/cureus.58892. eCollection 2024 Apr.
4
Unraveling the surface marker signature of cell-derived vesicles via proteome analysis and nanoparticle flow cytometry.通过蛋白质组分析和纳米颗粒流式细胞术揭示细胞衍生囊泡的表面标志物特征。
Sci Rep. 2024 Jan 2;14(1):121. doi: 10.1038/s41598-023-50279-x.
5
Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine.评估PastoCovac加强疫苗对已接种新冠病毒灭活疫苗个体的效果。
Heliyon. 2023 Sep 29;9(10):e20555. doi: 10.1016/j.heliyon.2023.e20555. eCollection 2023 Oct.
6
The Role of Adult Vaccines as Part of Antimicrobial Stewardship: A Scoping Review.成人疫苗作为抗菌药物管理一部分的作用：一项范围综述
Antibiotics (Basel). 2023 Sep 10;12(9):1429. doi: 10.3390/antibiotics12091429.
7
Impact of COVID-19 vaccination on COVID-19 hospital admissions in England during 2021: an observational study.2021 年英格兰 COVID-19 疫苗接种对 COVID-19 住院的影响：一项观察性研究。
J R Soc Med. 2023 May;116(5):167-176. doi: 10.1177/01410768231157017. Epub 2023 Feb 24.
8
COVID-19 vaccine hesitancy among health workers in rural Uganda: A mixed methods study.乌干达农村地区医护人员对新冠疫苗的犹豫态度：一项混合方法研究
Vaccine X. 2023 Apr;13:100260. doi: 10.1016/j.jvacx.2023.100260. Epub 2023 Jan 7.
9
Safety of Four COVID-19 Vaccines across Primary Doses 1, 2, 3 and Booster: A Prospective Cohort Study of Australian Community Pharmacy Vaccinations.四种新冠疫苗在第1、2、3剂主要剂量和加强针接种过程中的安全性：一项关于澳大利亚社区药房疫苗接种的前瞻性队列研究。
Vaccines (Basel). 2022 Nov 25;10(12):2017. doi: 10.3390/vaccines10122017.
10
Ethics and Effectiveness of US COVID-19 Vaccine Mandates and Vaccination Passports: A Review.美国 COVID-19 疫苗强制接种令和疫苗接种护照的伦理与效果：综述
J Res Health Sci. 2022 May 11;22(2):e00546. doi: 10.34172/jrhs.2022.81.
本文引用的文献
1
Interpreting vaccine efficacy trial results for infection and transmission.解读感染和传播疫苗效力试验结果。
Vaccine. 2021 Jul 5;39(30):4082-4088. doi: 10.1016/j.vaccine.2021.06.011. Epub 2021 Jun 12.
2
Avoiding exploitation in multinational covid-19 vaccine trials.避免在跨国新冠疫苗试验中出现剥削行为。
BMJ. 2021 Mar 4;372:n541. doi: 10.1136/bmj.n541.
3
Covid-19 vaccine hesitancy among ethnic minority groups.少数族裔群体对新冠疫苗的犹豫态度。
BMJ. 2021 Feb 26;372:n513. doi: 10.1136/bmj.n513.
4
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
5
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.欧洲药品管理局对新冠疫苗的欧盟有条件上市许可。
Lancet. 2021 Jan 30;397(10272):355-357. doi: 10.1016/S0140-6736(21)00085-4. Epub 2021 Jan 13.
6
Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination.新冠疫情：挪威对体弱老年患者接种疫苗后出现的23例死亡病例展开调查。
BMJ. 2021 Jan 15;372:n149. doi: 10.1136/bmj.n149.
7
Covid-19: People with history of significant allergic reactions should not receive Pfizer vaccine, says regulator.新冠疫情：监管机构称，有严重过敏反应史的人不应接种辉瑞疫苗。
BMJ. 2020 Dec 10;371:m4780. doi: 10.1136/bmj.m4780.
8
Vaccinating the UK against covid-19.为英国民众接种新冠疫苗。
BMJ. 2020 Nov 30;371:m4654. doi: 10.1136/bmj.m4654.
9
Bringing NHS data analysis into the 21st century.将国民医疗服务体系（NHS）数据分析带入21世纪。
J R Soc Med. 2020 Oct;113(10):383-388. doi: 10.1177/0141076820930666. Epub 2020 Jul 16.
10
Sources, uses, strengths and limitations of data collected in primary care in England.英格兰初级医疗保健中收集的数据的来源、用途、优势及局限性。
Health Stat Q. 2004 Spring(21):5-14.
Zotero 插件